Personalizing medicine for autoimmune and inflammatory diseases

Nature Immunology

Volumn 14, Issue 2, 2013, Pages 106-109

  Chan, Andrew C ^a   Behrens, Timothy W ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANASTROZOLE; BELIMUMAB; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CRIZOTINIB; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERLOTINIB; ESTROGEN RECEPTOR; FULVESTRANT; GEFITINIB; IMATINIB; IMMUNOGLOBULIN E; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 9; LEBRIKIZUMAB; ONARTUZUMAB; PERTUZUMAB; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; RAS PROTEIN; RILOTUMUMAB; STEM CELL FACTOR RECEPTOR; TAMOXIFEN; TRANSCRIPTION FACTOR RUNX2; TRASTUZUMAB; USTEKINUMAB; VEMURAFENIB;

ACUTE LYMPHOBLASTIC LEUKEMIA; ASTHMA; AUTOIMMUNE DISEASE; BREAST CANCER; CANCER THERAPY; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; CLINICAL OBSERVATION; COLORECTAL CANCER; CROHN DISEASE; ENTERITIS; ESOPHAGUS CANCER; FORCED EXPIRATORY VOLUME; GASTROINTESTINAL STROMAL TUMOR; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; INFLAMMATORY DISEASE; LIFE EXPECTANCY; LUNG NON SMALL CELL CANCER; MELANOMA; PATHOPHYSIOLOGY; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; STOMACH CANCER; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTINEOPLASTIC AGENTS; AUTOIMMUNE DISEASES; GENETIC HETEROGENEITY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INDIVIDUALIZED MEDICINE; INFLAMMATION; MOLECULAR TARGETED THERAPY; NEOPLASMS;

EID: 84872699046     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2473     Document Type: Review

References (19)

1. National Asthma Education and Prevention Program. J. Allergy Clin. Immunol. 120(5 Suppl.), S94-S138 (2007).
2. Capdeville, R., Buchdunger, E., Zimmermann, J. & Matter, A. Nat. Rev. Drug Discov. 1, 493-502 (2002).
3. Amado, R.G., et al. J. Clin. Oncol. 26, 1626-1634 (2008).
4. Wenzel, S.E. Nat. Med. 18, 716-725 (2012).
5. Moffatt, M.F. et al. N. Engl. J. Med. 363, 1211-1221 (2010).
6. Woodruff, P.G. et al. Am. J. Respir. Crit. Care Med. 180, 388-395 (2009).
7. Corren, J. et al. N. Engl. J. Med. 365, 1088-1098 (2011).
8. Navarra, S.V. et al. Lancet 377, 721-731 (2011).
9. Furie, R. et al. Arthritis Rheum. 63, 3918-3930 (2011).
10. Stohl, W. et al. Arthritis Rheum. 64, 2328-2337 (2012).
11. Santiago-Raber, M.L. et al. J. Exp. Med. 197, 777-788 (2003).
12. Baechler, E.C. et al. Proc. Natl. Acad. Sci. USA 100, 2610-2615 (2003).
13. Bennett, L. et al. J. Exp. Med. 197, 711-723 (2003).
14. Kirou, K.A. et al. Arthritis Rheum. 52, 1491-1503 (2005).
15. Imielinski, M. et al. Nat. Genet. 41, 1335-1340 (2009).
16. Sokol, H. & Seksik, P. Curr. Opin. Gastroenterol. 26, 327-331 (2010).
17. Sandborn, W.J. et al. Gastroenterology 135, 1130-1141 (2008).
18. Targan, S.R. et al. N. Engl. J. Med. 337, 1029-1035 (1997).
19. Hanauer, S.B. et al. Gastroenterology 130, 323-333 (2006).